Header Logo

Connection

Debra Ritzwoller to United States

This is a "connection" page, showing publications Debra Ritzwoller has written about United States.
Connection Strength

1.173
  1. Individuals Eligible for Lung Cancer Screening Less Likely to Receive Screening When Enrolled in Health Plans With Deductibles. Med Care. 2023 Oct 01; 61(10):665-673.
    View in: PubMed
    Score: 0.119
  2. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. JAMA Netw Open. 2021 10 01; 4(10):e2128176.
    View in: PubMed
    Score: 0.105
  3. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium. Cancer Prev Res (Phila). 2020 02; 13(2):129-136.
    View in: PubMed
    Score: 0.093
  4. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease. J Oncol Pract. 2019 07; 15(7):e616-e627.
    View in: PubMed
    Score: 0.089
  5. Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis. Health Serv Res. 2018 12; 53(6):5106-5128.
    View in: PubMed
    Score: 0.084
  6. Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm. J Natl Cancer Inst. 2018 03 01; 110(3):273-281.
    View in: PubMed
    Score: 0.082
  7. Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2017 12; 55(12):e88-e98.
    View in: PubMed
    Score: 0.080
  8. Advanced imaging among health maintenance organization enrollees with cancer. J Oncol Pract. 2014 Jul; 10(4):231-8.
    View in: PubMed
    Score: 0.063
  9. Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
    View in: PubMed
    Score: 0.060
  10. Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
    View in: PubMed
    Score: 0.056
  11. Viva bien!: Overcoming recruitment challenges in a multiple-risk-factor diabetes trial. Am J Health Behav. 2010 Jul-Aug; 34(4):432-41.
    View in: PubMed
    Score: 0.048
  12. Syndromic surveillance using minimum transfer of identifiable data: the example of the National Bioterrorism Syndromic Surveillance Demonstration Program. J Urban Health. 2003 Jun; 80(2 Suppl 1):i25-31.
    View in: PubMed
    Score: 0.029
  13. Virtual Care and Urinary Tract Infection Management: Comparing Ancillary Service Orders and Patient Order Fulfillments Between Virtual and In-person Encounters During the COVID-19 Pandemic in the United States. Med Care. 2023 04 01; 61(Suppl 1):S21-S29.
    View in: PubMed
    Score: 0.029
  14. Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
    View in: PubMed
    Score: 0.028
  15. Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021 03; 160(4):999-1002.
    View in: PubMed
    Score: 0.025
  16. Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders. Gen Hosp Psychiatry. 2020 Jan - Feb; 62:21-27.
    View in: PubMed
    Score: 0.023
  17. Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103.
    View in: PubMed
    Score: 0.021
  18. Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
    View in: PubMed
    Score: 0.020
  19. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323.
    View in: PubMed
    Score: 0.019
  20. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73.
    View in: PubMed
    Score: 0.016
  21. The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system. J Natl Cancer Inst Monogr. 2013; 2013(46):99-105.
    View in: PubMed
    Score: 0.014
  22. A standardized relative resource cost model for medical care: application to cancer control programs. J Natl Cancer Inst Monogr. 2013; 2013(46):106-16.
    View in: PubMed
    Score: 0.014
  23. Comparing cancer care, outcomes, and costs across health systems: charting the course. J Natl Cancer Inst Monogr. 2013; 2013(46):124-30.
    View in: PubMed
    Score: 0.014
  24. Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research. Med Care. 2009 Oct; 47(10):1091-7.
    View in: PubMed
    Score: 0.011
  25. National Bioterrorism Syndromic Surveillance Demonstration Program. MMWR Suppl. 2004 Sep 24; 53:43-9.
    View in: PubMed
    Score: 0.008
  26. Tobacco control efforts in managed care: what do the doctors think? Am J Manag Care. 2004 Mar; 10(3):193-8.
    View in: PubMed
    Score: 0.008
  27. Does payment drive procedures? Payment for specialty services and procedure rate variations in 3 HMOs. Am J Manag Care. 2004 Mar; 10(3):229-37.
    View in: PubMed
    Score: 0.008
  28. Extending health maintenance organization insurance to the uninsured. A controlled measure of health care utilization. JAMA. 1997 Apr 02; 277(13):1067-72.
    View in: PubMed
    Score: 0.005

© 2024 Kaiser Permanente